Birchtech Corp. ( BCHT ) on Wednesday said it promoted Jim Trettel to chief operating officer, elevating the longtime executive who previously served as executive vice president of operations. Trettel, who joined the specialty activated carbon technology company in 2014, will oversee corporate operations, including financial, administrative, engineering, and field systems functions. He has more th...
Birchtech Corp. ( BCHT ) on Wednesday said it promoted Jim Trettel to chief operating officer, elevating the longtime executive who previously served as executive vice president of operations. Trettel, who joined the specialty activated carbon technology company in 2014, will oversee corporate operations, including financial, administrative, engineering, and field systems functions. He has more than 36 years of experience in the dry bulk material-handling industry. More on Birchtech Birchtech Corp. (BCHT) Q1 2026 Earnings Call Transcript Birchtech Corp. (BCHTD) Q4 2025 Earnings Call Transcript Birchtech reports Q1 results Quant snapshot: Beachbody, Deutsche Telekom among top-rated names as IceCure Medical, Fold Holdings lag Seeking Alpha’s Quant Rating on Birchtech
Inflation has surged to its highest level in more than three years since the U.S. and Israel launched their war on Iran, triggering a surge in gasoline prices. (Image credit: Joe Raedle)
Inflation has surged to its highest level in more than three years since the U.S. and Israel launched their war on Iran, triggering a surge in gasoline prices. (Image credit: Joe Raedle)
The London Company, an investment management company, released its first-quarter 2026 investor letter for its “The London Company Income Equity Strategy”. A copy of the letter is available to download here. In early 2026, US equities declined, with the Russell 3000 falling 4% and the S&P posting losses. The year began positively on a broad […]
The London Company, an investment management company, released its first-quarter 2026 investor letter for its “The London Company Income Equity Strategy”. A copy of the letter is available to download here. In early 2026, US equities declined, with the Russell 3000 falling 4% and the S&P posting losses. The year began positively on a broad […]
Decart is launching Oasis 3, a real-time world model that generates photorealistic driving environments for autonomous vehicle testing, now available via API for developers to build on.
Decart is launching Oasis 3, a real-time world model that generates photorealistic driving environments for autonomous vehicle testing, now available via API for developers to build on.
国医疗职业培训平台 Stepful 近日宣布完成 5500 万美元 C 轮融资,由 Oak HC/FT 领投。 过去两年,Stepful 先后完成 3150 万美元 B 轮融资和 5500 万美元 C 轮融资。相比教育科技行业中更受关注的 AI 工具、学习平台和企业培训公司,这家职业教育公司的业务并不复杂:培训医疗助理、药剂技术员和外科技术员。资本为什么会持续押注这样一家企业? 320 万医疗人才...
国医疗职业培训平台 Stepful 近日宣布完成 5500 万美元 C 轮融资,由 Oak HC/FT 领投。 过去两年,Stepful 先后完成 3150 万美元 B 轮融资和 5500 万美元 C 轮融资。相比教育科技行业中更受关注的 AI 工具、学习平台和企业培训公司,这家职业教育公司的业务并不复杂:培训医疗助理、药剂技术员和外科技术员。资本为什么会持续押注这样一家企业? 320 万医疗人才缺口,催生 5500 万美元融资 本轮融资由 Oak HC/FT 领投,Foresite Capital、Hearst Ventures、Citi Impact Fund 等机构参与投资。SemperVirens、Y Combinator、ECMC Education Impact Fund 和 Intermountain Health 等现有投资者继续跟投。 这是 Oak HC/FT 连续第二次领投 Stepful。2024 年,该机构曾领投 Stepful 3150 万美元 B 轮融资。 连续两轮融资背后,是美国医疗行业长期存在的人才短缺问题。 美国医院协会预计,到 2026 年,美国医疗体系将面临约 320 万名医疗相关从业人员缺口。与此同时,美国医疗机构每年用于合同工和临时人员的支出已经达到约 970 亿美元。 在需求持续增长的同时,医疗人才培养体系扩张速度相对有限。长期以来,美国大量医疗辅助岗位人才主要由职业学校和社区学院培养,但受招生规模、场地资源以及培训周期等因素影响,这些机构很难快速扩大供给。 对于医疗机构而言, 人才短缺带来的影响正在不断扩大。 一方面,医院需要持续招聘新的医疗从业人员;另一方面,为填补岗位空缺而增加的临时用工支出也在不断增长。 在这样的背景下,医疗人才培养逐渐成为投资机构关注的新方向。作为长期专注医疗健康领域的投资机构,Oak HC/FT 在融资公告中表示,Stepful 是其见过的少数能够将在线教育与人工智能结合,并规模化解决医疗人才供给问题的公司之一。 Stepful不卖课程而是向医院输送人才 与传统职业学校不同,Stepful 并不将自己定位为一家单纯提供课程的教育机构。 公司采用「School-as-a-Service (学校即服务)」模式, 将职业培训、资格认证、临床实践和就业输送整合在同一体系中。 相比以招生和授课为核心的传统...
Gizem Gecim/iStock via Getty Images Major Middle Eastern sovereign wealth funds are seeking multibillion-dollar stakes in SpaceX's ( SPCX ) upcoming initial public offering, Bloomberg News reported Wednesday, citing people familiar with the matter. The orders underscore the region's growing influence in financing the global artificial intelligence and technology sectors Saudi Arabia's Public Inves...
Gizem Gecim/iStock via Getty Images Major Middle Eastern sovereign wealth funds are seeking multibillion-dollar stakes in SpaceX's ( SPCX ) upcoming initial public offering, Bloomberg News reported Wednesday, citing people familiar with the matter. The orders underscore the region's growing influence in financing the global artificial intelligence and technology sectors Saudi Arabia's Public Investment Fund and Kuwait Investment Authority have each submitted orders valued between $1 billion and $5 billion. Qatar Investment Authority is also expected to participate with a sizable investment. The interest comes amid intense demand for the offering from institutional investors worldwide. Orders have reportedly exceeded the number of shares available, with some investors seeking allocations worth more than $10 billion. For investors, the strong appetite from Gulf sovereign wealth funds highlights both the scale of demand for the SpaceX ( SPCX ) IPO and the increasingly important role Middle Eastern capital plays in supporting leading technology and AI companies. The investments could also provide one of the first opportunities for Gulf funds to realize gains from years of backing AI-related ventures and infrastructure. Several Gulf investors already have exposure to SpaceX and Elon Musk's broader business empire through direct and indirect holdings. As a result, part of their participation in the IPO may be aimed at maintaining ownership stakes following the company's public debut. The offering is also viewed as a key test of the investment strategies pursued by Gulf states, which have deployed hundreds of billions of dollars into artificial intelligence, data centers, semiconductor infrastructure and emerging technology companies. Those investments have accelerated as countries such as Saudi Arabia, the United Arab Emirates and Qatar seek to diversify their economies beyond oil. Saudi Arabia's PIF, for example, gained additional exposure to SpaceX this year through a m...
Alexis Putellas leads a host of stars expected to arrive in the WSL but smaller clubs will still struggle to keep pace The whistle has blown on the 2025-26 season for the vast majority of women’s teams around the world, and attention now turns to the hullabaloo of the transfer window and another summer of rising wages, transfer fees and agents fees. This summer’s activity is likely to see the gap ...
Alexis Putellas leads a host of stars expected to arrive in the WSL but smaller clubs will still struggle to keep pace The whistle has blown on the 2025-26 season for the vast majority of women’s teams around the world, and attention now turns to the hullabaloo of the transfer window and another summer of rising wages, transfer fees and agents fees. This summer’s activity is likely to see the gap between the haves and the have-nots widen further. Last summer there was an 83.6% increase in global spending on transfer fees in women’s football year-on-year, according to Fifa. This included headline-grabbing moves such as London City Lionesses’ £1.43m purchase of Grace Geyoro from Paris Saint-Germain, albeit London City have denied the figure is that high, and Arsenal’s landmark first £1m deal – the signing of Olivia Smith from Liverpool. This is an extract from our free email about women’s football, Moving the Goalposts. To get the full edition, visit this page and follow the instructions . Moving the Goalposts will be sent out once a week, on Wednesdays, in the close season but will be back on Tuesdays and Thursdays from September. Continue reading...
zimmytws/iStock via Getty Images Clover Health ( CLOV ) added more than 10% in the premarket on Wednesday after the health insurer announced that the Centers for Medicare & Medicaid Services (CMS) has upgraded its Medicare Star Ratings for 2026 following a court order. The company sued the U.S. Department of Health and Human Services after the CMS rated its PPO Medicare Advantage plan with 3.5 Sta...
zimmytws/iStock via Getty Images Clover Health ( CLOV ) added more than 10% in the premarket on Wednesday after the health insurer announced that the Centers for Medicare & Medicaid Services (CMS) has upgraded its Medicare Star Ratings for 2026 following a court order. The company sued the U.S. Department of Health and Human Services after the CMS rated its PPO Medicare Advantage plan with 3.5 Stars last year based on a scale used to award bonus payments to top-rated health plans. In a regulatory filing on Wednesday, the company said that on May 29, a federal court in Georgia set aside the calculation and ordered the CMS to recalculate its 2026 Star Rating, which impacts the 2027 payment year. The company added that the recalculated Star Rating, as communicated by the CMS on June 9, indicates 4.5 Stars for its PPO MA plan, which caters to 97% of its members. However, its HMO Medicare Advantage plan, which was not subject to the lawsuit, continues to hold 4.0 Stars for 2026. More on Clover Health Clover Health's Bullish Setup Still Looks Compelling Clover Health Investments, Corp. (CLOV) Q1 2026 Earnings Call Transcript Clover Health Investments, Corp. 2026 Q1 - Results - Earnings Call Presentation Clover targets 100-150 bps SG&A improvement in 2026 while expecting full-year GAAP net income profitability Clover Health GAAP EPS of $0.05 beats by $0.02, revenue of $749.2M beats by $34.31M